Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Return on Equity (2016 - 2025)

Marimed (MRMD) has disclosed Return on Equity for 14 consecutive years, with 0.27% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 8.0% to 0.27% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.27% through Dec 2025, down 8.0% year-over-year, with the annual reading at 0.27% for FY2025, 7.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.27% at Marimed, up from 0.32% in the prior quarter.
  • The five-year high for Return on Equity was 1.01% in Q2 2021, with the low at 0.32% in Q3 2025.
  • Average Return on Equity over 5 years is 0.07%, with a median of 0.01% recorded in 2023.
  • The sharpest move saw Return on Equity plummeted -8449bps in 2021, then increased 4bps in 2022.
  • Over 5 years, Return on Equity stood at 0.21% in 2021, then rose by 17bps to 0.25% in 2022, then tumbled by -186bps to 0.22% in 2023, then increased by 10bps to 0.19% in 2024, then tumbled by -42bps to 0.27% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.27%, 0.32%, and 0.28% for Q4 2025, Q3 2025, and Q2 2025 respectively.